Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Innovative drug delivery systems for leprosy treatment

da Rocha NP, Barbosa EJ, Barros de Araujo GL, et al. Scientific Scholar. Indian Journal of Dermatology, Venereology and Leprology. 2022;
Download PDF
Publication

LA DURACIÓN ACTUAL DE UN AÑO PARA LA POLIQUIMIOTERAPIA DE LOS PACIENTES MB (12 MESES) MANTIENE BUENOS RESULTADOS CLÍNICOS DURANTE AÑOS

Lockwood D, Butlin CR, Penna GO. Fontilles. Revista de leprología. 2021; 33 (2) : 133-138.
Publication

Peran Disregulasi Imunitas dalam Terapi Kusta pada Area Endemis: Artikel Review

Prakoeswa FRS, Maharani F. Faculty of Pharmacy, Mulawarman University. Jurnal Sains dan Kesehatan. 2022; 4 (1) : 99-104.
Download PDF
Publication

Diffuse multibacillary leprosy with Lucio’s phenomenon in east Lombok, west Nusa Tenggara, Indonesia

Widjaya SC, Mariam L. Comprehensive Publications. International Journal of Dermatology, Venereology and Leprosy Sciences. 2021; 4 (2) : 25-28.
Download PDF
Publication

Single-lesion paucibacillary leprosy: a retrospective study of 75 cases treated with the ROM scheme.

Pennini SN, França J, Rebello P, et al. Anais brasileiros de dermatologia. 2022;
Download PDF
Publication

Follow-up assessment of patients with Pure Neural Leprosy in a reference center in Rio de Janeiro-Brazil.

Pitta IJR, Hacker M, Andrade L, et al. PLoS neglected tropical diseases. 2022; 16 (1) : e0010070.
Download PDF
Publication

Leprosy Relapse: a Retrospective Study on Epidemiological, Clinical and Therapeutics Aspects at a Brazilian Referral Center.

Nascimento A, Santos D, Antunes D, et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2022;
Download PDF
Publication

Benefits of high dose clofazimine

Butlin CR, Maghanoy AA. Lepra. Leprosy Review. 2021; 92 (4) : 427-432.
Download PDF
Publication

Skin microbiome dysbiosis in leprosy cases

Teng VC, Esti PK. Medip Academy. International Journal of Research in Dermatology. 2021; 7 (5) : 741.
Download PDF
Publication

Treatment and Evaluation Advances in Leprosy Neuropathy.

Ebenezer G, Scollard D. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2021;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 25
  • Next page ››
Subscribe to Multi-drug therapy (MDT)

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD